BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31562977)

  • 1. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression.
    Mo J; Li B; Zhou Y; Xu Y; Jiang H; Cheng X; Wu X; Zhang Y
    Biomed Pharmacother; 2019 Dec; 120():109403. PubMed ID: 31562977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Stress Induced Non-Coding Transcripts 5 (LSINCT5) Promotes Hepatocellular Carcinoma Progression Through Interaction with High-Mobility Group AT-hook 2 and MiR-4516.
    Li O; Li Z; Tang Q; Li Y; Yuan S; Shen Y; Zhang Z; Li N; Chu K; Lei G
    Med Sci Monit; 2018 Nov; 24():8510-8523. PubMed ID: 30472720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
    Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S
    J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
    Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
    Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
    Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
    Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.
    Wang Y; Chen F; Zhao M; Yang Z; Li J; Zhang S; Zhang W; Ye L; Zhang X
    J Biol Chem; 2017 Sep; 292(37):15395-15407. PubMed ID: 28765279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12.
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
    Huang W; Li J; Guo X; Zhao Y; Yuan X
    Biomed Pharmacother; 2016 Jul; 81():431-438. PubMed ID: 27261623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression.
    Wang J; Zhang Y; Lu L; Lu Y; Tang Q; Pu J
    J Cell Biochem; 2019 Nov; 120(11):18816-18825. PubMed ID: 31297882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.
    Xuan W; Zhou C; You G
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32249890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis.
    Huang H; Bu YZ; Zhang XY; Liu J; Zhu LY; Fang Y
    J Cell Physiol; 2019 May; 234(5):6116-6124. PubMed ID: 30317567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression.
    Gao J; Yin X; Yu X; Dai C; Zhou F
    J Cell Biochem; 2019 Oct; 120(10):16393-16407. PubMed ID: 31270840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
    Han S; Han B; Li Z; Sun D
    Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.
    Xu R; Yin S; Zheng M; Pei X; Ji X
    Dig Dis Sci; 2021 Dec; 66(12):4361-4373. PubMed ID: 33433801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.